Abstract The stem of the Akebia plant, ''Mokutsu'', is a crude diuretic and antiphlogistic drug. Japanese products prepared from wild Akebia plants cover most of the Mokutsu market. Two Akebia plants, Akebia quinata Decaisne (Aq) and A. trifoliata Koidzumi (At) of Lardizabalaceae, are standardized as Mokutsu in Japanese pharmacopoeia. These two Akebia plants along with A. 9 pentaphylla Makino (Ap), which is considered a hybrid with the morphology of Aq and At, can be distinguished by DNA sequence analysis of internal transcribed spacers 1 and 2 (ITS) of nuclear ribosome DNA. Here, we report the results of molecular genetic analysis of Akebia plants grown in various wild habitats in Japan. We found that each of three Akebia plants could be distinguished in terms of their locality according to their nucleotide sequence in ITS, specifically at positions 91, 128, 133, 134, and 221. Plants with a comparable habitat had similar nucleotide sequences at these five points. We also found Aq with ITS and nucleotide deletion at position 86 that was distributed only around Awajishima in Shikoku (A), Harimanada (B), and Kinki (C), including the chief production center of Akebia Caulis. The results of these ITS sequences enabled discrimination of plants originating from Akebia Caulis.
Introduction
The stems of Akebia quinata Decaisne (Aq) and A. trifoliata Koidzumi (At) of Lardizabalaceae are prescribed as the Kampo crude drug ''Akebia Caulis'', ''Mokutsu'' in Japanese, in the modern Japanese pharmacopoeia [1] . Mokutsu is effective as a diuretic and an antiphlogistic, and the Japanese products cover most of the Mokutsu market [1, 2] . Akebia plants were morphologically identified by the shapes and number of the leaves, and also the size and color of the flowers. A. quinata usually has five oval-shaped leaflets and white or pale purple male and female flowers. A. trifoliata has three wavyedged leaflets and deep purple male and female flowers [3, 4] , but there is another Akebia plant, A. 9 pentaphylla Makino (Ap), which is considered a hybrid of A. quinata and A. trifoliata. The typical morphology of A. 9 pentaphylla has five leaflets with slightly wavy edges and pale purple male and female flowers [3, 4] , although sometimes individuals have boundary morphologies of A. quinata and A. 9 pentaphylla as well as A. trifoliata and A. 9 pentaphylla. It is difficult to distinguish the species from crude drugs prepared from these Akebia plants. For proper usage of the crude drugs, well-defined methods for specifying plants species are necessary. DNA analysis is a practical way to identify medicinal plants as well as crude drugs [5] [6] [7] . Previously, we found that these three Akebia plants can be distinguished by DNA sequence analysis of internal transcribed spacers 1 and 2 (ITS) [8] . Here, we report the results of molecular genetic analysis of Akebia plants grown in various wild habitats in Japan. We focus on the genetic distinction of Akebia plants according to their habitat.
Materials and methods

Plant and crude drug materials
Akebia specimens were collected in various parts of Japan (Fig. 1) . The plants were identified by the color and morphology of flowers as well as the shape and number of the leaves. Representative specimen and crude drug numbers and information on the collection sites are given in Table 1 .
Isolation of total DNA
About 50-to 70-mg portions of the dried leaves of collected specimens were frozen in liquid nitrogen and ground into fine powder. Total DNA isolation from the powder was performed using a DNeasy Plant Mini Kit (QIAGEN, Venlo, the Netherlands) according to the manufacturer's protocol with minor modifications.
PCR amplification
Amplification of the ITS region was performed by polymerase chain reaction (PCR) using 100-120 ng of total DNA as a template in 25 ll of reaction mixture containing 2.5 ll of 910 PCR buffer for KOD-Plus, 0.2 mM of each dNTP, 1.0 mM of MgSO 4 , 0.5 U of KOD-Plus DNA polymerase (TOYOBO, Osaka, Japan), and 0.4 lM of each primer Akebi-f (GCT CCT ACC GAT TGA ATG GT) and Ake-26SR (GTA AGT TTC TTC TCC TCC GC). Amplification was carried out under the following conditions: hot start at 94°C for 2 min, 30 cycles of denaturation at 94°C for 15 s, annealing at 55°C for 30 s and extension at 68°C for 45 s, and a final extension at 68°C for 5 min. Three microliters of the PCR product was analyzed by agarose gel electrophoresis and then the remaining product was purified using a QIA quick PCR Purification Kit (QIAGEN).
Sequencing procedure
The purified PCR product was subjected to direct sequencing using a BigDye Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) with an ABI PRISM 310 Genetic Analyzer (Applied Biosystems). The primers, Akebi-f and Ake-26SR, were used to prime the sequencing reactions of the ITS region. DNA sequences were aligned using DNASIS (version 3.0) software (Hitachi, Tokyo, Japan).
ITS cloning procedure
The ITS region of total DNA was amplified by PCR using the tagged primer set Ake-HD-F (TAA AAA GCT TGC TCC TAC CGA TTG AAT GGT) and ER-Ake-26SR (TTA TGA ATT CGT AAG TTT CTT CTC CTC CGC). After purification using the QIA Quick PCR Purification Kit (QIAGEN), 100-to 200-ng portions of the PCR products were digested with restriction enzymes Hind III and EcoR I (Takara Biotech) in 10 ll reaction mixture containing 10 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 1 mM dithiothreitol, and 50 mM NaCl at 37°C for 1 h, and then the reaction mixture was heated at 70°C for 15 min. Four-microliter aliquots of the reaction mixtures were combined with 5 ng of the plasmid Bluescript SK (-) digested with the same enzymes and 5 ll of DNA Ligation Kit Ver.2.1 (Takara Biotech). The ligation reaction was performed at 16°C overnight. Competent cells (Competent high DH5a, Toyobo) were transformed with the ligated product as recommended by the manufacturer's protocol. The transformed cells were spread on Luria broth (LB) agar plates containing ampicillin (Amp) (2% tryptone, 1% extract yeast dried, 2% NaCl, 3% agar, and 100 lg/ml ampicillin) and incubated at 37°C overnight. Bacterial colonies were picked up separately, and subcultured in liquid LB medium containing ampicillin (100 lg/ml). After overnight incubation, the bacteria were collected by centrifugation and plasmids were obtained by following the standard protocol [9] . DNA was extracted by alkaline isolation of plasmid DNA. Plasmid DNA was treated with RNase A, and then deposited by using polyethylene glycol. The sediment was used as a template when amplifying the ITS region by PCR. The PCR product was purified and then subjected to direct sequencing. Results and discussion
Comparison of ITS sequences of Aq, At, and Ap collected in various habitats
Samples were collected from various wild habitats as shown in Table 1 and Fig. 1 . Intensive field searches were performed in Shikoku (A), Harimanada (B), Kinki (C), Shimane prefecture (D), Kitakyusyu (E), and Ishikawa prefecture (F), collecting and analyzing 61, 54, 52, 26, 23, and 12 specimens, respectively. Previously, we found that two Akebia plants can be distinguished by DNA sequence analysis of the ITS region. Table 2 shows examples of ITS sequences of specimens morphologically identified as Aq, Ap, and At. Among these areas, Shikoku (A) is the chief production center of Akebia Caulis. The ITS region of some specimens morphologically identified as Aq, such as A-3, was subjected to the cloning procedure, since their sequences were unclear due to overlapping sequences. Sequencing analysis was performed using the clones of plasmids containing the ITS region. We found that these species had overlapping common ITS of Aq and that with nucleotide deletion at position 86. Direct sequencing together with the cloning result showed sequence uniformity within Aq or At specimens, while 19 nucleotide differences were found between these two species. Likewise, those of specimens identified as Ap could not be analyzed by direct sequencing. The cloning results showed that Ap had both common sequences of Aq and At (Table 2) , which clearly indicates that Ap is a hybrid of Aq Comparison of ITS sequence of Akebia plants grown in different localities Table 3 shows distinguishable features of the ITS sequence of Akebia plants collected from various habitats. For example, at nucleotide 91, Aq from Harimanada (B) and Kinki (C) were T and At was C, respectively. Both Aq and At of specimens from Shikoku (A) had equal T/C. The Sea of Japan showed almost totally T for Aq and At. As another example, G was found at nucleotide 128 for specimens from all habitats and species, except that At from Ishikawa was T. Furthermore, Aq with overlapping common sequences and deletion at position 86 was found in specimens collected in Shikoku (A), Harimanada (B), and Kinki (C). Table 4 shows the incidence of Aq with nucleotide deletion at position 86 for each prefecture. Aq with nucleotide deletion at position 86 appeared mainly around Harimanada and Awajishima. We found the specimens identified morphologically as Aq and At had respective common ITS sequences, which were distinguishable from each other [8] . In recent years, the chemical analysis of leaves, stems, and bark of At and Aq revealed that they had distinguishable triterpene profiles [10] [11] [12] . Comparison of triterpene-rich fractions of extracts from Akebia plants by TLC found that Ap had an intermediate profile to Aq and At [8] . The Aq specimens with a deletion were only found in a limited area, which contained the chief production center of Akebia Caulis. It is interesting whether the Aq specimens with a deletion have different chemical constituents and medical properties to other specimens. Furthermore, the ITS sequence analysis of crude drug suggested that Lot US262208-1, Lot US262208-2, and T068 originated from Aq of Shikoku (A), whereas T057 was from Ap. Thus, combined examination of these sequences in ITS made it possible to discriminate plants originating from Akebia Caulis. 
